JAK2 and thyroid gland carcinoma: We found that overexpression of JAK2 could partially reverse the change of p-STAT3, E-cadherin and N-cadherin protein levels induced by oridonin in thyroid cancer TPC-1 and BCPAP cells (Fig. 4C and 4D).